# A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-phase-ii-study-of-biweekly-dose-intensified-oral-capecitabine-plus-irinotecan/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sang Cheul Oh,Halil Yılmaz Sur,Hwa Jung Sung,I. Choi,Sung Soo Park,Jae Hong Seo,Yoon Tae Jeen,Hoon Jai Chun,Sang Won Shin,Young Jae Mok,J. S. Kim,Yeul Hong Kim |
| Citations | 15 |
| DOI | 10.1038/sj.bjc.6603752 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.nature.com/articles/6603752.pdf |
| OpenAlex ID | https://openalex.org/W2004330164 |
| PMID | 17473829 |
| Type | article |
| Year | 2007 |

## Paper authors

- [J. S. Kim](https://scholariq.org/researchers/j-s-kim/)

## Paper journal

- [British Journal of Cancer](https://scholariq.org/journals/british-journal-of-cancer/)

## Paper primary topic

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Paper topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.